HCA Healthcare (HCA) Earnings Date & Reports

Key Takeaways

• HCA Healthcare is scheduled to report its third-quarter 2026 results on Tuesday, October 27, 2026, before the market opens.
• Wall Street consensus calls for earnings of roughly $6.75 per share on revenue of approximately $19.3 billion to $19.4 billion for the quarter.
• That would mark a year-over-year earnings decline of about 3% against the $6.96 per share reported in the prior-year quarter, alongside modest revenue growth of roughly 1%.
• HCA has beaten earnings per share (EPS) estimates in seven of its last eight quarters, most recently reporting $7.59 per share for the second quarter of 2026 versus a $7.56 consensus.
• Investors will closely watch labor costs, equivalent admissions, and revenue per equivalent admission, with rising operating expenses weighing on the outlook.
• Full-year 2026 consensus stands at about $78.58 billion in revenue and $29.45 in EPS, implying roughly 3.9% and 4.4% annual growth, respectively.
• For more detail on HCA's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for additional insights.
• You can also explore Trending AI Robots to see how AI-driven tools are scanning for actionable trading ideas across the market.

Earnings Context and Why It Matters

HCA Healthcare is one of the largest for-profit hospital operators in the United States, making its quarterly report a closely watched barometer for broader healthcare demand and cost trends. The upcoming print arrives as the industry absorbs elevated labor and supply costs, while the expiration of enhanced premium tax credits has raised concerns about uninsured patient volumes. HCA's results tend to move the stock materially, and the company has a strong track record of beating estimates. For investors, this report offers a timely read on admission volumes, pricing power, and expense management across a large, diversified hospital network.

Earnings Expectations

Analysts expect HCA Healthcare to report third-quarter 2026 EPS of approximately $6.75 per share, according to consensus figures from Zacks and TipRanks, with some estimates near $6.65 to $6.66. Revenue expectations cluster around $19.33 billion to $19.38 billion. By comparison, HCA earned $6.96 per share on revenue of $19.16 billion in the same quarter last year, meaning consensus points to a roughly 3% decline in earnings on roughly 1% revenue growth.

Historically, HCA has delivered positive surprises more often than not, beating EPS in seven of the last eight quarters. The stock rose about 1.5% the day after its most recent report. Key metrics to watch include equivalent admissions, inpatient revenue per admission, occupancy rates, and revenue per equivalent admission, where consensus suggests some year-over-year softness that could pressure the top line.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. If you are looking for a faster way to identify setups around earnings events like HCA's, exploring the AI Screener is a practical next step.

Market Reaction and Investor Sentiment

Sentiment heading into the report is cautious but constructive. HCA shares have gained ground over the past several months, and the stock holds a Moderate Buy consensus rating from analysts, with an average price target around $455. However, the expected year-over-year earnings decline reflects concerns about rising operating costs and moderating revenue growth, which could limit upside if results merely meet expectations. A key risk is that labor and other operating expenses grow faster than revenue, compressing margins. Investors will also look for management commentary on uninsured patient volumes and the potential earnings headwind tied to expiring premium tax credits.

Forward Outlook and Key Factors to Monitor

Beyond the headline figures, investors should focus on what management says about the trajectory of patient volumes and pricing. Equivalent admissions and revenue per equivalent admission will indicate whether demand and reimbursement trends are holding up, while occupancy rates offer a gauge of capacity utilization across the hospital network.

Cost discipline remains the central variable. Salaries and benefits are the largest expense line for hospital operators, and any sign that wage pressure is stabilizing or easing would be a positive signal. Conversely, persistent increases in labor and other operating expenses could weigh on margins even if revenue grows.

Finally, watch for updates to full-year 2026 guidance. Consensus currently implies roughly $29.45 in annual EPS on about $78.58 billion in revenue, and any adjustment to that outlook could shape sentiment. Broader policy factors, including the status of premium tax credits and state-level Medicaid directed payment programs, also remain important swing factors for the hospital sector in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations